Recent

% | $
Quotes you view appear here for quick access.

Forest Laboratories Inc. Message Board

lost_space_ranger 8 posts  |  Last Activity: May 22, 2015 11:10 AM Member since: Jul 19, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • lost_space_ranger by lost_space_ranger Apr 28, 2015 7:38 AM Flag

    Not conv at 6 cents--read the 8k

    .... The Series G Preferred Stock may also be converted into shares of common stock at the option of the Company if the Equity Conditions, as defined in the Certificate of Designation, are met. Upon conversion, the Company shall pay the holders of the Series G Preferred Stock being converted a conversion premium equal to the amount of dividends that such shares would have otherwise earned if they had been held through the maturity date, and issue to the Investor such number of shares of Common stock equal to $5,000 per share of Series G Preferred Stock (the “Face Value”) multiplied by the number of Series G Preferred Stock divided by the conversion rate of $0.06.

    The conversion premium may be paid in cash or, at the Company’s option, additional shares of common stock. If the Company elects to pay the conversion premium amount in the form of common stock the number of shares to be issued shall be calculated by using 80% of the average of the lowest 5 individual daily volume weighted average prices during the measuring period, not to exceed 100% of the lowest sales prices on the last day of such period, less $0.005 per share of common stock.. Following an Event of Default, the number of shares to be issued shall be calculated by using 65% of the average of the lowest 5 individual daily volume weighted average prices during the measuring, less $0.005 per share of common stock not to exceed 70% of the lowest sales prices on the last day

    ITS TOXIC shs conv at 80% of mkt not 6 cents

  • lost_space_ranger by lost_space_ranger Apr 19, 2015 2:05 PM Flag

    Do we know for sure that the stem cells in the ReNeuron trial are covered by the CUR license agreement. Facts please no speculation

  • lost_space_ranger by lost_space_ranger Mar 5, 2015 11:53 AM Flag

    why toxic convert.financing?
    why don't they have a reputable investment banker?
    Why don't they have a deal with big pharma?

    not much here- that s why its 8 cents

  • lost_space_ranger by lost_space_ranger Apr 21, 2015 6:53 AM Flag

    well the stock price action says it all. Whatever the relationship, the stroke study obviously isn't covered by the license / milestone agreement Market up, Biotechs up (look at CLDX) this is down.

  • Reply to

    New CUSIP Number

    by smittysghost May 22, 2015 10:34 AM
    lost_space_ranger lost_space_ranger May 22, 2015 11:08 AM Flag

    brokers have a re org dept that takes care of name changes- mergers etc cusip # changes too

  • looks like that's where jnj is heading

  • Reply to

    New CUSIP Number

    by smittysghost May 22, 2015 10:34 AM
    lost_space_ranger lost_space_ranger May 22, 2015 11:07 AM Flag

    you know nothing

    changing a cusip has nothing to do with short selling-

    your broker will still show you short and you won't have to cover

  • Reply to

    Reverse

    by lt_toxic May 22, 2015 8:07 AM
    lost_space_ranger lost_space_ranger May 22, 2015 11:10 AM Flag

    dummy there's no reason for a halt--

FRX
0.00(0.00%)